Table 4.7.
Therapeutic biological products administered by the nasal cavity (nasal administration)
| Company | Product | Description |
|---|---|---|
| Sanofi-Aventis | Kryptocur® | Nasal administration of luteinizing hormone-releasing Hormone (LHRH) |
| Novartis | Miacalsin® | Nasal administration of salmon calcitonin |
| Unigene Laboratories/Upsher-Smith Laboratories, Inc. | Fortical® | Nasal administration of salmon calcitonin |
| Ferring Pharmaceuticals, Inc. | Desmospray® | Nasal administration of desmopressin (analog of 8-arginine vasopressin (ADH) |
| Sanofi-Aventis | Suprecur | Buserelin (agonist of LHRH) |
| Sanofi-Aventis | Suprefact | Buserelin (agonist of LHRH) |